Literature DB >> 9834489

Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

L D Rosenstein1.   

Abstract

There is a preponderance of research on the neuropsychology of the various dementias. There are also direct comparisons between two or more dementias available in the literature. This paper sought to summarize the most recent literature, primarily from 1990 through mid-1996, including recent reviews of the literature from previous decades. The purpose was to provide, in one location, a summary of neuropsychological (i.e., cognitive, motor, and psychiatric) characteristics of major noninfectious, progressive dementias and depression of middle and late adulthood. It is hoped that this review, particularly a summary table provided, will serve as a guide in the differential diagnosis of the dementias by clinicians. In addition to Alzheimer's disease, vascular dementias, Parkinson's disease, Lewy body dementia, Huntington's disease, and frontal lobe dementia, the impact of depression on cognitive functioning is covered given the frequency with which neuropsychologists are asked to differentiate depression from primary dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9834489     DOI: 10.1023/a:1025628925796

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  208 in total

1.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Binswanger's disease: some neuropsychological considerations.

Authors:  D J Libon; M Scanlon; R Swenson; H B Coslet
Journal:  J Geriatr Psychiatry Neurol       Date:  1990 Jan-Mar       Impact factor: 2.680

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

Review 5.  Cognitive problems in the elderly.

Authors:  G Dal Forno; C H Kawas
Journal:  Curr Opin Neurol       Date:  1995-08       Impact factor: 5.710

6.  Clinical and neuropathological findings in Lewy body dementias.

Authors:  D Galasko; R Katzman; D P Salmon; L Hansen
Journal:  Brain Cogn       Date:  1996-07       Impact factor: 2.310

7.  Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  B Pillon; B Deweer; Y Agid; B Dubois
Journal:  Arch Neurol       Date:  1993-04

8.  Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment.

Authors:  J J Downes; H M Sharp; B M Costall; H J Sagar; J Howe
Journal:  Brain       Date:  1993-08       Impact factor: 13.501

9.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

Review 10.  Progress and controversies in neuropsychology of memory.

Authors:  G Gainotti; C Marra
Journal:  Acta Neurol (Napoli)       Date:  1992 Aug-Dec
View more
  17 in total

Review 1.  Executive control functions in degenerative dementias: a comparative review.

Authors:  L M Duke; A W Kaszniak
Journal:  Neuropsychol Rev       Date:  2000-06       Impact factor: 7.444

2.  Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Efficacy of a medical food on cognition in Alzheimer's disease: results from secondary analyses of a randomized, controlled trial.

Authors:  P J G H Kamphuis; F R J Verhey; M G M Olde Rikkert; J W R Twisk; S H N Swinkels; P Scheltens
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 4.  [Diagnosis and clinical therapy for Parkinson's disease].

Authors:  S Wenzel; B Mollenhauer; C Trenkwalder
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

5.  Forgetting in dementia with and without subcortical lacunes.

Authors:  Joel H Kramer; Dan Mungas; Bruce R Reed; Norbert Schuff; Michael W Weiner; Bruce L Miller; Helena C Chui
Journal:  Clin Neuropsychol       Date:  2004-02       Impact factor: 3.535

6.  End-of Life Issues in the Context of Alzheimer's Disease.

Authors:  Rebecca S Allen; Jung Kwak; Kristine L Lokken; William E Haley
Journal:  Alzheimers Care Q       Date:  2003-10-01

7.  Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.

Authors:  Jeffrey L Cummings; Martin R Farlow; Xiangyi Meng; Sibel Tekin; Jason T Olin
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 8.  Depression in adults: drug and physical treatments.

Authors:  Andrea Cipriani; Corrado Barbui; Rob Butler; Simon Hatcher; John Geddes
Journal:  BMJ Clin Evid       Date:  2011-05-25

Review 9.  Depression in adults: psychological treatments and care pathways.

Authors:  Jonathan Price; Rob Butler; Simon Hatcher; Michael Von Korff
Journal:  BMJ Clin Evid       Date:  2007-08-15

Review 10.  Depression in adults: drug and physical treatments.

Authors:  Corrado Barbui; Rob Butler; Andrea Cipriani; John Geddes; Simon Hatcher
Journal:  BMJ Clin Evid       Date:  2007-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.